Association of endogenous retroviruses and long terminal repeats with human disorders

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Katoh, Iyoko ^a   Kurata, Shun Ichi ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Autoimmune; Cancer; HERV; Human endogenous retrovirus; Long terminal repeat; LTR; Retrotransposon

Indexed keywords

BRCA2 PROTEIN; COLONY STIMULATING FACTOR RECEPTOR; DNA; GAG PROTEIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; PROTEIN P53; PROTEIN P63; RNA DIRECTED DNA POLYMERASE; TRANSCRIPTION FACTOR; TRANSFER RNA; TUMOR ANTIGEN; UBIQUITIN PROTEIN LIGASE E3; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; BREAST CANCER; DNA METHYLATION; DNA TRANSPOSITION; ENDOGENOUS RETROVIRUS; EPIGENETICS; EVOLUTION; GENE EXPRESSION; GENOME; HODGKIN DISEASE; HUMAN; HUMAN GENOME; KIDNEY CARCINOMA; LONG TERMINAL REPEAT; MAMMAL; NEOPLASM; NONHUMAN; PATHOGENESIS; RETROPOSON; TRANSCRIPTION INITIATION; TRANSPOSON; TUMOR IMMUNITY; VIRUS ONCOGENE;

EID: 84891121699     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00234     Document Type: Article

References (109)

1. Sverdlov ED. Retroviruses and primate evolution. Bioessays (2000) 22:161-71. doi:10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X
2. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A (2004) 101:14572-9. doi:10.1073/pnas.0404838101
3. Hughes JF, Coffin JM. Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome. Genetics (2005) 171:1183-94. doi:10.1534/genetics.105.043976
4. Moyes DL, Martin A, Sawcer S, Temperton N, Worthington J, Griffiths DJ, et al. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics (2005) 86:337-41. doi:10.1016/j.ygeno.2005.06.004
5. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature (2001) 409:860-921. doi:10.1038/35057062
6. Paces J, Pavlícek A, Paces V. HERVd: database of human endogenous retroviruses. Nucleic Acids Res (2002) 30:205-6. doi:10.1093/nar/30.1.205
7. Ribet D, Harper F, Dupressoir A, Dewannieux M, Pierron G, Heidmann T. An infectious progenitor for the murine IAP retrotransposon: emergence of an intracellular genetic parasite from an ancient retrovirus. Genome Res (2008) 18:597-609. doi:10.1101/gr.073486.107
8. Gifford WD, Pfaff SL, Macfarlan TS. Transposable elements as genetic regulatory substrates in early development. Trends Cell Biol (2013) 23:218-26. doi:10.1016/j.tcb.2013.01.001
9. Jurka J. Repbase update: a database and an electronic journal of repetitive elements. Trends Genet (2000) 16:418-20. doi:10.1016/S0168-9525(00)02093-X
10. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol (2000) 74:3715-30. doi:10.1128/JVI.74.8.3715-3730.2000
11. Mager DL, Medstrand P. Retroviral repeat sequences. In: Cooper D, editor. Nature Encyclopedia of the Human Genome. Hampshire: MacMillan Publishers (2003). p. 291-315.
12. Bénit L, Calteau A, Heidmann T. Characterization of the low-copy HERV-Fc family: evidence for recent integrations in primates of elements with coding envelope genes. Virology (2003) 312:159-68. doi:10.1016/S0042-6822(03)00163-6
13. Bannert N, Kurth R. The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet (2006) 7:149-73. doi:10.1146/annurev.genom.7.080505.115700
14. Subramanian R, Wildschutte J, Russo C, Coffin J. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology (2011) 8:90. doi:10.1186/1742-4690-8-90
15. Smit AFA. Identification of a new, abundant superfamily of mammalian LTR-transposons. Nucleic Acids Res (1993) 21:1863-72. doi:10.1093/nar/21.8.1863
16. Lynch C, Tristem M. A co-opted gypsy-type LTR-retrotransposon is conserved in the genomes of humans, sheep, mice, and rats. Curr Biol (2003) 13:1518-23. doi:10.1016/S0960-9822(03)00618-3
17. Cost GJ, Feng Q, Jacquier A, Boeke JD. Human L1 element target-primed reverse transcription in vitro. EMBO J (2002) 21:5899-910. doi:10.1093/emboj/cdf592
18. Dewannieux M, Esnault C, Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet (2003) 35:41-8. doi:10.1038/ng1223
19. Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet (2009) 10:691-703. doi:10.1038/nrg2640
20. Kano H, Godoy I, Courtney C, Vetter MR, Gerton GL, Ostertag EM, et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Gene Dev (2009) 23:1303-12. doi:10.1101/gad.1803909
21. Hancks DC, Kazazian HH Jr. SVA retrotransposons: evolution and genetic instability. Semin Cancer Biol (2010) 20:234-45. doi:10.1016/j.semcancer.2010.04.001
22. Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F, et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature (2011) 479:534-7. doi:10.1038/nature10531
23. Mills RE, Bennett EA, Iskow RC, Luttig CT, Tsui C, Pittard WS, et al. Recently mobilized transposons in the human and chimpanzee genomes. Am J Hum Genet (2006) 78:671-9. doi:10.1086/501028
24. Li X, Scaringe WA, Hill KA, Roberts S, Mengos A, Careri D, et al. Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat (2001) 17:511-9. doi:10.1002/humu.1134
25. Deininger PL, Moran JV, Batzer MA, Kazazian HH Jr. Mobile elements and mammalian genome evolution. Curr Opin Genet Dev (2003) 13:651-8.
26. Chen JM, Stenson PD, Cooper DN, Ferec C. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet (2005) 117:411-27. doi:10.1007/s00439-005-1321-0
27. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell (2010) 141:1253-61. doi:10.1016/j.cell.2010.05.020
28. Hancks DC, Kazazian HH Jr. Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 22:191-203. doi:10.1016/j.gde.2012.02.006
29. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol (2005) 22:814-7. doi:10.1093/molbev/msi088
30. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res (2006) 16:1548-56. doi:10.1101/gr.5565706
31. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, Lenz J. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol (1999) 9:861-S861. doi:10.1016/S0960-9822(99)80390-X
32. Shin W, Lee J, Son SY, Ahn K, Kim HS, Han K. Human-specific HERV-K insertion causes genomic variations in the human genome. PLoS One (2013) 8:e60605. doi:10.1371/journal.pone.0060605
33. Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, Wachter DJ, et al. Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before homo sapiens. Mol Biol Evol (2009) 26:2617-26. doi:10.1093/molbev/msp180
34. Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, Hudson RR, et al. Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS One (2011) 6:e20234. doi:10.1371/journal.pone.0020234
35. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol (2001) 11:1531-5. doi:10.1016/S0960-9822(01)00455-9
36. Ling J, Pi W, Bollag R, Zeng S, Keskintepe M, Saliman H, et al. The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol (2002) 76:2410-23. doi:10.1128/jvi.76.5.2410-2423.2002
37. Vogt VM. Retroviral virions and genomes. In: Coffin JM, Hughes JF, Varmus HE, editors. Retroviruses. New York: Cold Spring Harbor Laboratory Press (1997). p. 27-69.
38. Kawakami K, Scheidereit C, Roeder RG. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci U S A (1988) 85:4700-4. doi:10.1073/pnas.85.13.4700
39. Katoh I, Yoshinaka Y, Ikawa Y. Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF. EMBO J (1989) 8:497-503.
40. Beimling P, Moelling K. Direct interaction of CREB protein with 21 bp tax-response elements of HTLV-ILTR. Oncogene (1992) 7:257-62.
41. Kurata S. Sensitization of the HIV-1-LTR upon long term low dose oxidative stress. J Biol Chem (1996) 271:21798-802.
42. Fuchs NV, Kraft M, Tondera C, Hanschmann KM, Lower J, Lower R. Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. J Virol (2011) 85:3436-48. doi:10.1128/JVI.02539-10
43. Katoh I, Mirova A, Kurata S, Murakami Y, Horikawa K, Nakakuki N, et al. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M. Neoplasia (2011) 13:1081-92.
44. Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol (2001) 2:REVIEWS1017. doi:10.1186/gb-2001-2-6-reviews1017
45. Cohen CJ, Lock WM, Mager DL. Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene (2009) 448:105-14. doi:10.1016/j.gene.2009.06.020
46. Dunn CA, Medstrand P, Mager DL. An endogenous retroviral long terminal repeat is the dominant promoter for human beta1,3-galactosyltransferase 5 in the colon. Proc Natl Acad Sci U S A (2003) 100:12841-6. doi:10.1073/pnas.2134464100
47. Bièche I, Laurent A, Laurendeau I, Duret L, Giovangrandi Y, Frendo J-L, et al. Placenta-specific INSL4 expression is mediated by a human endogenous retrovirus element. Biol Reprod (2003) 68:1422-9. doi:10.1095/biolreprod.102.010322
48. Landry J-R, Mager DL. Functional analysis of the endogenous retroviral promoter of the human endothelin B receptor gene. J Virol (2003) 77:7459-66. doi:10.1128/JVI.77.13.7459-7466.2003
49. Ting CN, Rosenberg MP, Snow CM, Samuelson LC, Meisler MH. Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev (1992) 6:1457-65. doi:10.1101/gad.6.8.1457
50. Samuelson LC, Phillips RS, Swanberg LJ. Amylase gene structures in primates: retroposon insertions and promoter evolution. Mol Biol Evol (1996) 13:767-79. doi:10.1093/oxfordjournals.molbev.a025637
51. Pi W, Zhu X, Wu M, Wang Y, Fulzele S, Eroglu A, et al. Long-range function of an intergenic retrotransposon. Proc Natl Acad Sci U S A (2010) 107:12992-7. doi:10.1073/pnas.1004139107
52. Yu X, Zhu X, Pi W, Ling J, Ko L, Takeda Y, et al. The long terminal repeat (LTR) of ERV-9 human endogenous retrovirus binds to NF-Y in the assembly of an active LTR enhancer complex NF-Y/MZF1/GATA-2. J Biol Chem (2005) 280:35184-94. doi:10.1074/jbc.M508138200
53. Beyer U, Moll-Rocek J, Moll UM, Dobbelstein M. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci U S A (2011) 108:3624-9. doi:10.1073/pnas.1016201108
54. Costas J, Naveira H. Evolutionary history of the human endogenous retrovirus family ERV9. Mol Biol Evol (2000) 17:320-30. doi:10.1093/oxfordjournals.molbev.a026312
55. Mi S, Lee X, Li X-P, Veldman GM, Finnerty H, Racie L, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature (2000) 403:785-9. doi:10.1038/35001608
56. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, et al. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A (2007) 104:20534-9. doi:10.1073/pnas.0707873105
57. Dupressoir A, Vernochet C, Harper F, Guégan J, Dessen P, Pierron G, et al. A pair of co-opted retroviral envelope syncytin genes is required for formation of the two-layered murine placental syncytiotrophoblast. Proc Natl Acad Sci U S A (2011) 108:E1164-73. doi:10.1073/pnas.1112304108
58. Prudhomme S, Oriol G, Mallet F. A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol (2004) 78:12157-68. doi:10.1128/JVI.78.22.12157-12168.2004
59. Rosenberg N, Jolicoeur P. Retroviral pathogenesis. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. New York: Cold Spring Harbor Laboratory Press (1997). p. 475-585.
60. Aizawa S, Suda Y, Furuta Y, Yagi T, Takeda N, Watanabe N, et al. Env-derived gp55 gene of friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells. EMBO J (1990) 9:2107-16.
61. Yoshimura A, D'Andrea AD, Lodish HF. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A (1990) 87:4139-43. doi:10.1073/pnas.87.11.4139
62. Bishop JM. Cellular oncogenes and retroviruses. Annu Rev Biochem (1983) 52:301-54. doi:10.1146/annurev.bi.52.070183.001505
63. Löwer R, Löwer J, Tondera-Koch C, Kurth R. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. Virology (1993) 192:501-11. doi:10.1006/viro.1993.1066
64. Armbruester V, Sauter M, Roemer K, Best B, Hahn S, Nty A, et al. Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X. J Virol (2004) 78:10310-9. doi:10.1128/JVI.78.19.10310-10319.2004
65. Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, et al. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene (2005) 24:3223-8. doi:10.1038/sj.onc.1208543
66. Hanke K, Chudak C, Kurth R, Bannert N. The Rec protein of HERV-K(HML-2) upregulates androgen receptor activity by binding to the human small glutamine-rich tetratricopeptide repeat protein (hSGT). Int J Cancer (2013) 132:556-67. doi:10.1002/ijc.27693
67. Schmitt K, Reichrath J, Roesch A, Meese E, Mayer J. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome Biol Evol (2013) 5:307-28. doi:10.1093/gbe/evt010
68. Romanish MT, Cohen CJ, Mager DL. Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol (2010) 20:246-53. doi:10.1016/j.semcancer.2010.05.005
69. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res (2003) 63:8735-41.
70. Büscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res (2005) 65:4172-80. doi:10.1158/0008-5472.CAN-04-2983
71. Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, et al. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia (2008) 10:521-33.
72. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res (2008) 68:5869-77. doi:10.1158/0008-5472.CAN-07-6838
73. Boller K, König H, Sauter M, Mueller-Lantzsch N, Löwer R, Löwer J, et al. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology (1993) 196:349-53. doi:10.1006/viro.1993.1487
74. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A (1993) 90:4480-4. doi:10.1073/pnas.90.10.4480
75. Sauter M, Schommer S, Kremmer E, Remberger K, Dolken G, Lemm I, et al. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol (1995) 69:414-21.
76. Sauter M, Roemer K, Best B, Afting M, Schommer S, Seitz G, et al. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res (1996) 56:4362-5.
77. Agoni L, Guha C, Lenz J. Detection of human endogenous retrovirus K (HERV-K) transcripts in human prostate cancer cell lines. Front Oncol (2013) 3:180. doi:10.3389/fonc.2013.00180
78. Alves PM, Levy N, Stevenson BJ, Bouzourene H, Theiler G, Bricard G, et al. Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer. Cancer Immun (2008) 8:11.
79. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer (2007) 120:81-90. doi:10.1002/ijc.22256
80. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature (2007) 447:425-32. doi:10.1038/nature05918
81. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene (2002) 21:5400-13. doi:10.1038/sj.onc.1205651
82. Wild L, Flanagan JM. Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta (2010) 1806:50-7. doi:10.1016/j.bbcan.2010.03.003
83. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta (2007) 1775:138-62.
84. Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis (2011) 32:1484-92. doi:10.1093/carcin/bgr181
85. Iramaneerat K, Rattanatunyong P, Khemapech N, Triratanachat S, Mutirangura A. HERV-K hypomethylation in ovarian clear cell carcinoma is associated with a poor prognosis and platinum resistance. Int J Gynecol Cancer (2011) 21:51-7. doi:10.1097/IGC.0b013e3182021c1a
86. Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer (2004) 3:12. doi:10.1186/1476-4598-3-12
87. Wentzensen N, Coy JF, Knaebel HP, Linnebacher M, Wilz B, Gebert J, et al. Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers. Int J Cancer (2007) 121:1417-23. doi:10.1002/ijc.22826
88. Gimenez J, Montgiraud C, Pichon J-P, Bonnaud B, Arsac M, Ruel K, et al. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res (2010) 38:2229-46. doi:10.1093/nar/gkp1214
89. Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, et al. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest (2008) 118:1099-109. doi:10.1172/JCI34409
90. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, et al. Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene (2011) 30:4697-706. doi:10.1038/onc.2011.179
91. Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med (2010) 16:571-9. doi:10.1038/nm.2129
92. Nakagawa K, Brusic V, McColl G, Harrison LC. Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum (1997) 40:627-38. doi:10.1002/art.1780400407
93. Sicat J, Sutkowski N, Huber BT. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol (2005) 32:1821-31.
94. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler (2012) 18:1721-36. doi:10.1177/1352458512441381
95. Laska MJ, Brudek T, Nissen KK, Christensen T, Møller-Larsen A, Petersen T, et al. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol (2012) 86:3713-22. doi:10.1128/JVI.06723-11
96. Tai A, O'Reilly E, Alroy K, Simon K, Munger K, Huber B, et al. Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler (2008) 14:1175-80. doi:10.1177/1352458508094641
97. de la Hera B, Varadé J, García-Montojo M, Lamas JR, de la Encarnación A, Arroyo R, et al. Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis. PLoS One (2013) 8:e62090. doi:10.1371/journal.pone.0062090
98. Garcia-Montojo M, Varade J, Villafuertes E, Hera BD, Hoyas-Fernandez J, Dominguez-Mozo M, et al. Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients. Scand J Rheumatol (2013). doi:10.3109/03009742.2013.779021
99. Molès JP, Tesniere A, Guilhou JJ. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Br J Dermatol (2005) 153:83-9. doi:10.1111/j.1365-2133.2005.06555.x
100. Nelson PN, Hooley P, Roden D, Davari Ejtehadi H, Rylance P, Warren P, et al. Human endogenous retroviruses: transposable elements with potential? Clin Exp Immunol (2004) 138:1-9.
101. Tugnet N, Rylance P, Roden D, Trela M, Nelson P. Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link? Open Rheumatol J (2013) 7:13-21. doi:10.2174/1874312901307010013
102. Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, et al. Interferon-a-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity (2001) 15:591-601. doi:10.1016/S1074-7613(01)00212-6
103. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity (2001) 15:579-89. doi:10.1016/S1074-7613(01)00210-2
104. Seidl C, Donner H, Petershofen E, Usadel KH, Seifried E, Kaltwasser JP, et al. An endogenous retroviral long terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis. Hum Immunol (1999) 60:63-8. doi:10.1016/S0198-8859(98)00095-0
105. Pascual M, Martin J, Nieto A, Giphart MJ, van der Slik AR, de Vries RR, et al. Distribution of HERV-LTR elements in the 5'-flanking region of HLA-DQB1 and association with autoimmunity. Immunogenetics (2001) 53:114-8. doi:10.1007/s002510100307
106. Pani MA, Seidl C, Bieda K, Seissler J, Krause M, Seifried E, et al. Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin Endocrinol (2002) 56:773-7. doi:10.1046/j.1365-2265.2002.t01-1-01548.x
107. Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, et al. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol (2010) 160:340-7. doi:10.1111/j.1365-2249.2010.04110.x
108. Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell (2012) 22:38-51. doi:10.1016/j.devcel.2011.11.013
109. Nakkuntod J, Sukkapan P, Avihingsanon Y, Mutirangura A, Hirankarn N. DNA methylation of human endogenous retrovirus in systemic lupus erythematosus. J Hum Genet (2013) 58:241-9. doi:10.1038/jhg.2013.6